Mylan obtained final FDA approval for its clonidine transdermal system, a copy of Boehringer Ingelheim's hypertension treatment Catapres-TTS. The generic-drug maker said shipment of the product is expected immediately.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||